Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US OKs Access' "most affordable" AEDs (automated external defibrillators):

This article was originally published in Clinica

Executive Summary

Access CardioSystems has gained US market clearance for two automated external defibrillators (AEDs) which it claims are cheaper than rival products. The AccessAED and AccessALS AEDs are "clinically advanced devices", which, when equipped with electrodes and battery, weigh just 2.8lbs and measure only 3.0" x 7.3" x 4.3", says the Concord, Massachusetts firm. They offer a substantial financial value when compared to devices offered from Philips, Medtronic Physio-Control, Zoll Medical and Cardiac Science, claims the company. In many cases, says the firm, customers budgeting for one of these devices are now able to purchase two Access CardioSystems' devices.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068062

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel